Vistin Pharma ASA: Invitation to Q2 2023 conference call
August 16, 2023 06:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 16 August 2023 Vistin Pharma ASA will release its second quarter and YTD 2023 results on Wednesday 23rd of August 2023. Vistin Pharma will host a conference call for all shareholders...
Management in Vistin Pharma ASA purchases shares
July 04, 2023 02:30 ET
|
Vistin Pharma ASA
4 July 2023: Vistin Pharma ASA (the “Company”) has on 4 July 2023 sold shares to members of its management team for its long-term incentive plan (LTIP), as approved by the general meeting on the 22...
Vistin Pharma ASA: Results of offer to buy back shares
July 04, 2023 02:00 ET
|
Vistin Pharma ASA
4 July 2023: Reference is made to the stock exchange release of Vistin Pharma ASA (“Vistin” or the "Company") dated 30 June 2023 at 07:30 hours CEST concerning an offer to buy back shares (the...
Vistin Pharma ASA: Offer to buy back shares
June 30, 2023 01:30 ET
|
Vistin Pharma ASA
30 June 2023: Vistin Pharma ASA (the “Company”) has decided to launch an offer to all shareholders in the Company to buy back up to 250,000 shares in the Company in connection with its Long Term...
Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day
June 14, 2023 09:15 ET
|
Vistin Pharma ASA
Attached is today's presentation held in relation to Vistin Pharma's Capital Markets Day at the Metformin manufacturing plant in Kragerø.
Attachment
Capital Markets...
Vistin Pharma ASA: Mandatory notification of trade
May 31, 2023 06:05 ET
|
Vistin Pharma ASA
Magnus Tolleshaug, Chief Commercial Officer in Vistin Pharma ASA, and a primary insider, has on 31st of May 2023 purchased 15.000 shares in Vistin Pharma ASA at an average price of NOK 24,01 per...
Vistin Pharma ASA: Mandatory notification of trade
May 30, 2023 15:00 ET
|
Vistin Pharma ASA
Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares,...
Vistin Pharma ASA: Minutes from the Annual General Meeting 2023
May 22, 2023 08:52 ET
|
Vistin Pharma ASA
Oslo, Norway, 22 May 2023 Vistin Pharma ASA (OSE: VISTIN): Please find attached the minutes from the Annual General Meeting held today, on the 22 May 2023. All matters were resolved as proposed...
Disclosure of voting rights at AGM in Vistin Pharma ASA
May 12, 2023 11:30 ET
|
Vistin Pharma ASA
In relation to the Annual General Meeting in Vistin Pharma ASA on the 22nd of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 3 905 611 shares...
Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø
May 11, 2023 05:00 ET
|
Vistin Pharma ASA
Vistin Pharma will host a Capital Markets Day (CMD) for all interested parties on the 14th of June at its production plant in Stuttlidalen 4 at Fikkjebakke in Kragerø. The invitation is attached. ...